Nalaganje...
Rational use of cetuximab in the treatment of advanced non-small cell lung cancer
Lung cancer is the leading cause of mortality in the United States. Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancers. Most NSCLC patients present with loco-regionally advanced or metastatic disease where response rates are low and median overall survival approxim...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2009
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2886327/ https://ncbi.nlm.nih.gov/pubmed/20616912 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|